Acute Charcot's arthropathy of the foot and ankle

Physical Therapy

Volumn 78, Issue 1, 1998, Pages 74-80

  Armstrong, David G ^a   Lavery, Lawrence A ^a  

^a NONE

Author keywords

Ankle and foot; Arthropathy; Joint diseases; Lower extremity; Neurogenic

Indexed keywords

ANKLE; ARTHROPATHY; DIABETIC FOOT; FOOT; HIGH RISK POPULATION; HUMAN; MUSCULOSKELETAL SYSTEM; NEUROPATHIC JOINT DISEASE; NEUROPATHY; PREVALENCE; REVIEW;

EID: 0031961759     PISSN: 00319023     EISSN: None     Source Type: Journal    
DOI: 10.1093/ptj/78.1.74     Document Type: Review

References (37)

1. Armstrong DG, Todd WF, Lavery LA, Harkless LB. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med. 1997;14:357-363.
2. Sinha S, Munichoodapa CS, Kozak GP. Neuroarthropathy (Charcot joints) in diabetes mellitus. Medicine. 1972;51:191-210.
3. Kelly M. William Musgrave's De Arthritide Symptomatica (1703): his description of neuropathic arthritis. Bull Hist Med. 1963;37:372-376.
4. Charcot JM. Sur quelaques arthropathies qui paraissent depender d'une lesion du cerveau ou de la moele epiniere. Arch Des Physiol Norm et Path. 1868;1:161-171.
5. Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57:307-312.
6. Kelly M. John Kearsley Mitchell and the neurogenic theory of arthritis. J Hist Med Allied Sci. 1965;20:151-157.
7. Eloesser L. On the nature of neuropathic affections of the joint. Ann Surg. 1917;66:201-206.
8. Sanders LJ, Frykberg RG. Charcot's joint. In: Levin ME, O'Neal LW, Bowker JH, eds. The Diabetic Foot. 2nd ed. St Louis, Mo: Mosby-Year Book; 1993:149-180.
9. Finsterbush A, Friedman B. The effect of sensory denervation on rabbits' knee joints. J Bone Joint Surg Am. 1975:57:949-957.
10. Brower AC, Allman RM. The neuropathic joint: a neurovascular bone disorder. Radiol Clin North Am. 1981;19:571-579.
11. Edmonds ME, Clarke MB, Newton JB, et al. Increased uptake of radiopharmaceutical in diabetic neuropathy. QJM. 1985;57:843-855.
12. Todd WF, Laughner T, Samojla BG. The diabetic foot. In: Robbins JM, ed. Primary Podiatric Medicine. Philadelphia, Pa: WB Saunders Co; 1994:213-245.
13. Banks AS, McGlamry ED. Charcot foot. J Am Podiatr Med Assoc. 1989;79:213-217.
14. Lavery LA, Armstrong DG, Walker SC. Healing rates of diabetic foot ulcers associated with midfoot fracture due to Charcot's arthropathy. Diabet Med. 1997;14:46-49.
15. Armstrong DG, Lavery LA, Saraya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;34:280-283.
16. Armstrong DG, Perales TA, Murff R, et al. Value of white blood cell count with differential in the acute diabetic foot infection. J Am Podiatr Med Assoc. 1996;86:224-227.
17. Lavery LA, Armstrong DG, Quebedeaux TL, Walker SC. Puncture wounds: the frequency of normal laboratory values in the face of severe foot infections of the foot in diabetic and non-diabetic adults. Am J Med. 1996;101:521-525.
18. Keenen AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med. 1989;149:2262-2266.
19. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis. American Journal of Roentgenology. 1992;158:9.
20. Grayson ML, Balaugh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA. 1995;273:721-723.
21. Caputo GM. Infection: investigation and management. In: Boulton AJM, Connor H, Cavanagh PR, eds. The Foot in Diabetes. 2nd ed. Chichester, England: John Wiley & Sons Ltd; 1994:168-199.
22. Horwitz T. Bone and cartilage debris in the synovial membrane: its significance in the early diagnosis of neuroarthropathy. J Bone Joint Surg Am. 1948;30:579-588.
23. Eichenholz SN. Charcot Joints. Springfield, Ill: Charles C Thomas, Publisher; 1966.
24. Sanders LJ, Mrdjencovich D. Anatomical patterns of bone and joint destruction in neuropathic diabetics. Diabetes. 1991;40(suppl 1):529A.
25. Harris JR, Brand PW. Patterns of disintegration of the tarsus in the anesthetic foot. J Bone Joint Surg Br. 1966;48:4-16.
26. Armstrong DG, Lavery LA, Liswood PL, et al. Infrared dermal thermometry for the high-risk diabetic foot. Phys Ther. 1997;77: 169-177.
27. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997;34:317-321.
28. Armstrong DG, Lavery LA, Harkless LB. Treatment-based classification system for assessment and care of diabetic feet. J Am Podiatr Med Assoc. 1996;86:311-316.
29. Armstrong DG, Liswood PL, Todd WF. The contralateral limb during total contact casting: a dynamic pressure and thermometric analysis. J Am Podiatr Med Assoc. 1995;85:733-737.
30. Kominsky SJ. The ambulatory total contact cast. In: Frykberg RG, ed. The High-Risk Foot in Diabetes Mellitus. New York, NY: Churchill Livingstone Inc; 1991:449-455.
31. Armstrong DG, Lavery LA. Monitoring neuropathic ulcer healing with infrared dermal thermometry. J Foot Ankle Surg. 1996;35:335-338.
32. Clohisy DR, Thompson RC. Fractures associated with neuropathic arthropathy in adults who have juvenile-onset diabetes. J Bone Joint Surg Am. 1988;70:1192-1200.
33. Myerson MS, Henderson MR, Saxby T, Wilson-Short K. Management of midfoot diabetic neuroarthropathy. Foot Ankle. 1994;15: 233-241.
34. Lavery LA, Vela SA, Lavery DC, Quebedaux TL. Reducing dynamic foot pressures in high-risk diabetics with foot ulcerations: a comparison of treatments. Diabetes Care. 1996;19:818-821.
35. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med. 1994;11:28-31.
36. van der Pluijm G, Binderup L, Bramm E, et al. Disodium-1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivo. J Bone Miner Res. 1992;7:981-986.
37. Cohen M, Roman A, Lovins JE. Totally implanted direct current stimulator as treatment for a nonunion in the foot. J Foot Ankle Surg. 1993;32:375-381.